These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 3934087

  • 1. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS, Abernethy DR, Greenblatt DJ.
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [Abstract] [Full Text] [Related]

  • 2. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E, Polnaszek CF, Scheeler DA, Halsall HB, Eckfeldt JH, Holtzman JL.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [Abstract] [Full Text] [Related]

  • 3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A, Nishiura T, Ishino M, Yamamoto Y, Ogita I, Kiso Y, Takada K.
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [Abstract] [Full Text] [Related]

  • 4. Plasma protein binding of drugs after severe burn injury.
    Martyn JA, Abernethy DR, Greenblatt DJ.
    Clin Pharmacol Ther; 1984 Apr; 35(4):535-9. PubMed ID: 6705453
    [Abstract] [Full Text] [Related]

  • 5. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM, Moore P, Quon CY.
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [Abstract] [Full Text] [Related]

  • 6. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T, Thevanayagam LN, Blaschke TF, Au S, Stone JA, Jayewardene AL, Chi J, Aweeka FT.
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of serum protein binding of felodipine.
    Valle M, Esteban M, Rodríguez-Sasiaín JM, Calvo R, Aguirre C.
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [Abstract] [Full Text] [Related]

  • 8. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM, Bogaert MG.
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting serum protein binding of cocaine in humans.
    Parker RB, Williams CL, Laizure SC, Lima JJ.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [Abstract] [Full Text] [Related]

  • 10. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam.
    Davis D, Grossman SH, Kitchell BB, Shand DG, Routledge PA.
    Br J Clin Pharmacol; 1985 Feb; 19(2):261-5. PubMed ID: 3986083
    [Abstract] [Full Text] [Related]

  • 11. Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients.
    Freilich DI, Giardina EG.
    Clin Pharmacol Ther; 1984 May; 35(5):670-4. PubMed ID: 6713778
    [Abstract] [Full Text] [Related]

  • 12. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF, Dubé LM, Mousseau N, McGilveray I, Beanlands DS.
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [Abstract] [Full Text] [Related]

  • 13. Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
    Lee MH, Kim HJ, Kim SH, Kim SO, Lee DH, Lim H, Yoo SE, Lee MG.
    Res Commun Mol Pathol Pharmacol; 2001 Oct; 110(5-6):361-70. PubMed ID: 12889527
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
    Kays MB, White RL, Gatti G, Gambertoglio JG.
    Pharmacotherapy; 1992 Oct; 12(1):50-5. PubMed ID: 1549539
    [Abstract] [Full Text] [Related]

  • 15. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL, Slaughter RL, Edwards DJ, Lalka D.
    Eur J Clin Pharmacol; 1983 Oct; 25(3):413-7. PubMed ID: 6628530
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
    Moon YJ, Kim SH, Ryu CK, Lee MG.
    Res Commun Mol Pathol Pharmacol; 2000 Oct; 108(3-4):167-77. PubMed ID: 11913709
    [Abstract] [Full Text] [Related]

  • 17. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA, Mattson RH.
    Ther Drug Monit; 1979 Oct; 1(1):105-16. PubMed ID: 121944
    [Abstract] [Full Text] [Related]

  • 18. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
    Tiula E, Tallgren LG, Neuvonen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ, Slaughter RL, Pieper JA, Wyman MG, Lalka D.
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-acid glycoprotein and serum binding of drugs in healthy and diseased dogs.
    Belpaire FM, De Rick A, Dello C, Fraeyman N, Bogaert MG.
    J Vet Pharmacol Ther; 1987 Mar; 10(1):43-8. PubMed ID: 3586122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.